A tale of two cities

This headline caught my eye this morning.

"Cochlear breaks $1bn barrier"

Media are trumpeting Cochlear for reaching the $1bn revenue milestone.  So they should, Cochlear is a great Australian success story.

However, Slater & Gordon are virtually certain of breaking the $1bn revenue milestone too.  Another great Australian success story.  Will it be trumpeted in the same manner?

Before the alternatives pipe up, I'm well aware that revenue and profit and cash are different and revenues without profit is a different kettle of fish.

My point is, at face value it seems odd that some talk of Slater & Gordon as a speculative penny stock when it also about to post $1bn revenue, as Cochlear has.